| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| girentuximab i-124 | carbonic anhydrase ix | NA | Clinical trial target | TTD , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||